These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2468971)
1. Pathophysiology of hypertension: effects of calcium antagonists on heart and kidney. Frohlich ED J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S11-7. PubMed ID: 2468971 [TBL] [Abstract][Full Text] [Related]
2. Calcium antagonists for initial therapy of hypertension. Frohlich ED Heart Lung; 1989 Jul; 18(4):370-6. PubMed ID: 2663785 [TBL] [Abstract][Full Text] [Related]
3. End-organ disease in hypertension: what have we learned? Grossman E; Messerli FH J Cardiovasc Pharmacol; 1992; 20 Suppl 10():S1-6. PubMed ID: 1283425 [TBL] [Abstract][Full Text] [Related]
4. Reversal of target-organ involvement in systemic hypertension: a pharmacologic experience. Frohlich ED Am J Cardiol; 1987 Dec; 60(17):3I-7I. PubMed ID: 2961248 [TBL] [Abstract][Full Text] [Related]
5. Renal protection with calcium antagonism in essential hypertension. Bauer JH; Reams GP Clin Invest Med; 1989 Oct; 12(5):300-4. PubMed ID: 2689026 [TBL] [Abstract][Full Text] [Related]
6. Left ventricular function in hypertension. Relevance to the selection of antihypertensive therapy. Zusman RM Am J Hypertens; 1989 Jun; 2(6 Pt 2):200S-206S. PubMed ID: 2568846 [TBL] [Abstract][Full Text] [Related]
7. Renal effects of calcium antagonists with special reference to manidipine hydrochloride. Rodicio JL Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787 [TBL] [Abstract][Full Text] [Related]
8. [Are all antihypertensive drugs renoprotective?]. Wolf S; Risler T Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950 [TBL] [Abstract][Full Text] [Related]
9. Obesity-associated hypertension: hypothesized link between etiology and selection of therapy. Reisin E; Tuck ML Blood Press Monit; 1999; 4 Suppl 1():S23-6. PubMed ID: 10822414 [TBL] [Abstract][Full Text] [Related]
10. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617 [TBL] [Abstract][Full Text] [Related]
11. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists? Bauer JH; Reams GP J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071 [TBL] [Abstract][Full Text] [Related]
12. Renal haemodynamic and protective effects of calcium antagonists in hypertension. Zanchi A; Brunner HR; Waeber B; Burnier M J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898 [TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in chronic kidney disease. Toto RD Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269 [TBL] [Abstract][Full Text] [Related]
15. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
16. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings]. Klaus D Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016 [TBL] [Abstract][Full Text] [Related]
17. [Arterial hypertension in patients on chronic hemodialysis]. Zogović J; Mladenović Lj Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857 [TBL] [Abstract][Full Text] [Related]
18. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203 [TBL] [Abstract][Full Text] [Related]